October 15, 2019
The Ministry of Health, Labor and Welfare (MHLW) on October 11 withdrew orphan drug designation for two drugs including Chugai Pharmaceutical’s Actemra (tocilizumab) for the treatment of systemic scleroderma, SSc. Actemra was granted the orphan status for the SSc indication...read more